期刊文献+

用共聚焦显微镜研究plk1在秋水仙胺和长春新碱抗肿瘤效应中的作用

Role of plk1 in the anti-cancer effect of colcemid and vincri stine against K562 cells
下载PDF
导出
摘要 目的:研究plk1在秋水仙胺和长春新碱抗肿瘤效应中的作用。方法:采用Westernblotting和共聚焦显微镜检测秋水仙胺、长春新碱及plk1反义寡核苷酸(Asodn)处理对K5 6 2细胞plk1及γ微管蛋白表达的影响。结果:Westernblotting检测结果提示秋水仙胺和长春新碱不影响plk1和γ微管蛋白的表达量,但共聚焦显微镜观察发现秋水仙胺和长春新碱影响plk1在分裂期聚集和中心体形成。plk1Asodn处理不仅可明显降低plk1蛋白表达,而且影响γ微管蛋白聚合形成中心体。结论:秋水仙胺和长春新碱抗肿瘤效应可能是通过plk1介导的抑制γ微管蛋白聚合形成中心体来实现的,plk1具有作为肿瘤治疗靶点的可能性。 AIM: To study the role of plk1 in the ant i-cancer effect of colcemid and vincristine against K562 cells. METHODS: K562 cells were treated with colcemid and vincristine a nd antisense oligonucleotide of plk1, then expression of plk1 and γ-tubulin wer e investigated by Western blotting and confocal microscopy. RESULTS: Treatment of K562 cells with colcemid and vincristine i nfluenced the condensation of plk1 and assembly of γ-tubulin, though without ch ange of protein quantity. Treatment with antisense oligonucleotide of plk1 not o nly reduced the expression of plk1 without influence on protein quantity of γ-t ubulin detected by Western blotting, but also disturbed the formation of centros ome observed by confocal microscopy. CONCLUSION: The function of colcemid and vincristine destructing the spindle might be realized through the mechanism of restraining condensation of plk1 and assembly of γ-tubulin, which might be dependent on plk1. plk1 may be a potential target in anti-cancer therapy.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2005年第4期733-737,共5页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助课题 (No .30 2 714 72 )
关键词 K562细胞 秋水仙属 长春新碱 polo—like激酶 K562 cells Colchicum Vincristine Polo-like kinase
  • 相关文献

参考文献8

  • 1Elez R, Piiper A, Giannini CD, et al. Polo-like kinase 1, a new target for antisense tumor therapy[ J]. Biochem Biophys Res commun, 2000, 269(2): 352-356.
  • 2Smits VA, Klompmaker R, Arnaud L, et al. Polo-like kinase 1 is a target of the DNA damage checkpoint[J]. Nat Cell Biol, 2000, 2(9): 672-676.
  • 3Weichert W, Schmidt M, Gekeler V, et al. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades[J]. Prostate, 2004, 60(3): 240-245.
  • 4Gray PJ Jr, Bearss DJ, Han H, et al. Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer[J]. Mol Cancer Ther, 2004, 3(5): 641-646.
  • 5Ito Y, Miyoshi E, Sasaki N, et al. Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma[J]. Br J Cancer, 2004, 90(2): 414-418.
  • 6Ito Y, Yoshida H, Matsuzuka F, et al. Polo-like kinase 1 (PLK1) expression is associated with cell proliferative activity and cdc2 expression in malignant lymphoma of the thyroid[ J].Anticancer Res, 2004, 24(1): 259-263.
  • 7Tong C, Fan HY, Lian L, et al. Polo-like kinase 1 is pivotal regulator of microtubule assembly during mouse oocyte meiotic maturation, fertilization, and early embryonic mitosis [J]. Biol Reprod, 2002, 67(2): 546-554.
  • 8Lingle WL, Lutz WH, Ingle JN, et al. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity[J]. Proc Natl Acad Sci USA, 1998, 95(6):2950-2955.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部